Stocks and Investing
Stocks and Investing
Mon, June 12, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, June 9, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, June 8, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, June 7, 2017
[ 01:45 PM ] - United States, WOPRAI
[ 01:45 PM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Andrew Schenker Initiated (THC) at Hold and Held Target at $19 on, Jun 7th, 2017
Andrew Schenker of Morgan Stanley, Initiated "Tenet Healthcare Corporation" (THC) at Hold and Held Target at $19 on, Jun 7th, 2017.
Andrew has made no other calls on THC in the last 4 months.
There are 3 other peers that have a rating on THC. Out of the 3 peers that are also analyzing THC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Sheryl Skolnick of "Mizuho" Upgraded from Sell to Hold and Increased Target to $23 on, Friday, February 24th, 2017
These are the ratings of the 2 analyists that currently disagree with Andrew
- Gary Lieberman of "Wells Fargo" Upgraded from Hold to Buy on, Tuesday, June 6th, 2017
- Christopher Rigg of "Deutsche Bank" Initiated at Strong Buy and Held Target at $28 on, Wednesday, April 5th, 2017
Contributing Sources